Immediate Impact
7 hit
Citing Papers
Challenges and Opportunities in Cancer Drug Resistance
2020 Hit
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
2012 Hit
Works of Fabrizio Ciccone being referenced
Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia
2006